Chief Executive Officer
Jessica is a highly accomplished senior management professional in the biotech industry. During her tenure at a large biotech company, she played a key role in driving over $130MM in revenue through her strategic leadership and business acumen. Over the past 15 years, Jessica has been a strategic partner for the multiple universities in biochemistry and molecular biology, leading numerous successful business ventures.
As a Monoclonal and Polyclonal Antibody Expert, she possesses extensive knowledge and expertise in the field of immunology and antibody research. Her background involves in-depth research on the production, characterization, and application of both monoclonal and polyclonal antibodies. She has been actively involved in developing novel antibody-based therapies, conducting experiments to validate their efficacy, and optimizing antibody production techniques.
Jessica’s extensive expertise in the biotech industry has earned her recognition as a member of the Canadian Association of Drug and Policy Management (CADPM). She is passionate about developing innovative solutions for complex medical challenges and is committed to driving advancements in the field of biomedicine. With her impressive track record and deep understanding of the industry, Jessica is poised to continue making significant contributions to the biotech industry in the years to come.
Aside from her professional achievements, Jessica is also actively involved in supporting women in business. She serves on the board of a non-profit organization that helps women entrepreneurs and is an advocate for women in the finance industry. Her expertise in strategic planning, financial analysis, and risk management has been critical to her success, and her commitment to mentoring and supporting women in business is inspiring.